The cardiovascular effects of a single dose of two short-acting intravenous anaesthetics, methohexitone and propanidid, were studied in ten healthy male volunteers. The doses used were selected to produce clinical anaesthesia of similar depth and duration. Methohexitone increased heart rate initially without changing arterial or filling pressures. The C(a-v) 02 difference was decreased, suggesting an increased cardiac output. The heart rate increase was of the same order of magnitude, indicating no important negative inotropic effect. Propanidid initially decreased arterial pressure and increased heart rate. Fining pressures increased slightly. The C(a-v) 02 difference decreased to the same extent as after methohexitone. A relatively larger increase in heart rate and increases in filling pressures point to a more clearcut negative inotropic effect. However, it would seem that with both agents the effect is predominantly peripheral.
The response of an intact organism to intravenous injection of a short-acting barbiturate is complex. Most authors have found a slight decrease in arterial pressure, an increase in heart rate and a 25-30 per cent decrease in cardiac output, although an increase in forearm blood flow has been described (Prime and Gray, 1952) . The interpretations of these results are divergent; some authors regard myocardial negative inotropic effects as the more important action of these agents (Gruber and Baskett, 1924; Olmstedt and Ogden, 1930; Gruber, 1937; Gordh, 1945; Woods, Wyngaarden and Seevers, 1949) . Others ascribe importance to changes in the peripheral vascular bed; a decrease in tone of the resistance vessels (Gruber and Baskett, 1925; Das, 1942) and of the capacity vessels (Eckstein, Hamilton and McCammond, 1961;  for review see Conway and Ellis, 1969) .
The circulatory effects of propanidid (Epontol) have been studied on isolated hearts (Astrom, Bernhoff and Persson, 1970) , on the rabbit heart in situ (Bernhoff, 1968) and on the dog and cat heart in situ (Langrehr, 1965) . A more pronounced negative inotropic effect is found than with barbiturates given in comparable doses (Astrom, Bernhoff and Persson, 1970) . The lowering of arterial pressure by propanidid in man (Langrehr, 1965; Johnstone and Barron, 1968) might, however, be due to effects on the peripheral circulation as well as on the heart. The aim of the present investigation was to compare some central and peripheral effects of propanidid and methohexitone in healthy volunteer subjects.
SUBJECTS AND PROCEDURES
Ten healthy male volunteers between the ages of 21 and 55 years were studied (table I) . Electrocardiograms taken at rest and during exercise prior to the study were normal in all subjects. Subjects were studied in the fasting state in the morning. Short teflon catheters were introduced percutaneously into both brachial arteries, using the Seldinger technique. The tip of a teflon or a Cournand catheter was placed in the right atrium percutaneously via a cubital vein, and via the contralateral cubital vein a Cournand double lumen catheter, size 8F, was introduced into the pulmonary artery and wedge position percutaneously according to Jonsson (1966) .
With the catheters in position, heart rate and arterial, right atrial and pulmonary capillary venous pressures were recorded during a control period. Arterial and mixed venous blood were sampled for the calculation of the arteriovenous oxygen content difference. The anaesthetic agent was then injected. All subjects were given both methohexitone and propanidid, with a resting period of 60 minutes between the injections, half of the subjects being given methohexitone first, and half propanidid first. In order to obtain anaesthesia of similar depth for 2-4 minutes either 7.5 mg/kg body weight of propanidid or 2.4 mg/kg of methohexitone was injected through the catheter in the pulmonary artery with a motordriven syringe. These doses were selected on the basis of the data of Howells (1965) and Clarke and associates (1968) . The injection time was 20-25 sec. Electrocardiogram, heart rate and arterial, right atrial and pulmonary capillary venous pressures were recorded continuously during the injections and for the following 10 minutes. Arterial and mixed venous blood were sampled at 0.5, 1, 1.5, 2, 3, 5, 10 and 60 minutes after the end of the infusion. In two subjects blood samples were also withdrawn and intravascular pressures recorded after 20, 30 and 40 minutes. Continuous heart rate and pressure recording as well as frequent blood sampling was performed in order to detect the maximum change of the variables studied and the average time at which it appeared.
For technical reasons only heart rate and arterial pressure were obtained in all ten subjects. Pulmonary capillary venous pressures were recorded in nine and right atrial pressure in eight subjects. In two cases, arterial and venous mixed oxygen saturation were not measured 10 minutes after infusion.
METHODS
Heart rate was determined from the electrocardiogram and continuously recorded as an analogue signal from a device measuring the inverted value of the R-R intervals (Medec Electronics, Stockholm).
Intravascular pressures were measured with strain gauge transducers (Medec Electronics, Stockolm), the mid-thoracic point being the reference level. Mean pressures were derived by electrical integration (time-constant 1 sec).
E.c.g., heart rate and pressures were recorded with • a UV-recorder (Oscillofil, Siemens).
Oxygen saturation and haemoglobin concentration of arterial and mixed venous blood were measured spectrophotometrically on a Beckman B spectrophotometer (Drabkin, 1950; Holmgren and Pernow, 1959) or on an Instrumentation Laboratories' COoxymeter (Gambino and Waraksa, 1969) for calculation of oxygen content and arteriovenous oxygen difference.
RESULTS
The values in the text are, when not otherwise stated, given as means. The findings are summarized in table II and figures 1 and 2.
Methohexitone.
After methohexitone infusion, the subjects slept for 4-7 minutes. Heart rate increased from 78.5 at rest to 112.9 beats/min (P<0.001) and remained slightly increased 10 minutes after the infusion (P<0.01). The maximum change in heart rate appeared 80 sec after the end of the infusion. Arterial mean pressure decreased in seven subjects and increased in three subjects. The average resting value was 97.8 mm Hg and the mean lowest value after the infusion 87.4 mm Hg. The difference is, however, not significant. The pulmonary capillary venous pressure was 11.2 mm Hg and the right atrial pressure 6.1 mm Hg at rest. During the first minute after infusion there were no significant changes in the filling pressures, but later they fell continuously; 10 minutes after the infusion they were significantly below control values, being 7.9 mm Hg (P<0.05) and 3.5 mm Hg (P<0.001), respectively. In the experiments in which methohexitone was used as the first agent, pressures were recorded also 60 minutes after infusion and had then returned to normal. In the two experiments with observations also at 20, 30
and 40 minutes, the filling pressures remained low for 30-40 min after methohexitone. Mixed venous oxygen saturation at rest was 75.3 per cent. In six subjects there was an increase during the first minute after methohexitone, in the remaining four it was unchanged or slightly decreased. On the average it increased to 77.9 per cent, the difference from control value being significant (P<0.05).
In all subjects the arterial oxygen saturation decreased, the mean value being 96.2 per cent before the infusion and 88.5 per cent 1£ minutes after the infusion (P<0.001).
The arteriovenous oxygen content difference decreased from 40.1 to 24.8 ml/1. 1^ minutes after the infusion (P<0.001).
During and immediately after the infusion there was, as estimated from the intra-thoracic pressure recordings, a period of hyperventilation of an average duration of 26 sec, followed by a short period of apnoea. Spontaneous breathing then started again with a period of intermittent breathing. 
Propanidid.
After propanidid infusion, the subjects in general woke up somewhat earlier than after methohexitone.
Thirty sec after the end of the injection, the brachial artery mean pressure had dropped from 99.1 to its lowest value of 70.3 mm Hg (P<0.001) and the heart rate increased from a mean of 79.1 to 124.0 beats/min (P<0.001). The difference in magnitude of change between propanidid and methohexitone (paired observations) is significant for the arterial mean pressure (P<0.01) but not for the heart rate (P>0.05).
The pulmonary capillary venous pressure rose from 11.2 to 16.1 mm Hg (P<0.001) and the right atrial pressure from 6.5 to 10.0 mm Hg (P<0.001) during the first minute.
Mixed venous oxygen saturation increased from 74.2 to 81.4 per cent (P<O.OD1), which is an increase significantly greater than after methohexitone (paired observations, P<0.001).
Arterial oxygen saturation decreased from 96.6 to 93.9 per cent (P<0.001), but this decrease was not as pronounced as after methohexitone, the difference in decrease calculated from paired observations being significant (P<0.01).
The arteriovenous oxygen content difference decreased from 42.9 ml/1, during the control period to a lowest value of 30.0 ml/1. (P<0.001) about 1 minute after the end of the infusion. The decrease is not significantly different from that found after methohexitone. In five of the subjects this initial decrease was followed by a slight increase above control level about 3 minutes after the infusion.
During the infusion the subjects started to hyperventilate. The period of hyperventilation was slightly longer than after methohexitone, on the average 44 sec (P<0.05), and was followed by similar intermittent breathing.
DISCUSSION
There is controversy as to what effects short-acting intravenous barbiturates have on the cardiovascular system. Conway and Ellis (1969) concluded that, while the exact mechanism of the arterial blood pressure fall is undecided for man, available evidence points to a reduction in cardiac output with or without a compensatory increase in total systemic vascular resistance.
In this study there was no significant change in arterial pressure after methohexitone infusion and the filling pressures were also unchanged initially.
At the same time the arteriovenous oxygen content difference decreased by 38 per cent. With the fast transient changes in cardiac output occurring after injection of the anaesthetic agents measurement of cardiac output with conventional methods is not possible. Oxygen uptake has been shown to decrease 10-30 per cent after 20 minutes of barbiturate anaesthesia slightly deeper than in the present study (Johnson, 1951) . Thus for the sake of discussion it seems reasonable to assume that during our short-term anaesthesia no major change in oxygen uptake has occurred.
Assuming an unchanged oxygen uptake, the cardiac output should have increased to the same degree as the arteriovenous oxygen content difference decreased. Heart rate increase was of the same order of magnitude. Consequently there should be no major change in stroke volume. A negative inotropic effect of barbiturates with the dose used thus seems to be of no importance. 2-3 minutes after the injection, there was a continuous fall in filling pressure. This lends support to the conclusion that barbiturates given intravenously decrease venomotor tone and lead to pooling of blood in the systemic capacity vessels, and thus is in accordance with the findings of several authors (Eckstein, Hamilton and McCammond, 1961; Watson, Seelye and Smith, 1962) .
Propanidid injection was followed by a significant fall in arterial pressure. The arteriovenous oxygen content difference decreased roughly to the same extent as after methohexitone suggesting a similar increase in cardiac output. With a larger increase, taken as a percentage, in heart rate than in estimated cardiac output, the stroke volume should be decreased. At the same time the filling pressures were increased. Thus the results may point to a slight negative inotropic effect and be in accordance with the findings of Bernhoff (1968) but the observations need further confirmation. However, the probability that the cardiac output increased seems to indicate that, with propanidid as well as with barbiturates, effects on the peripheral vascular bed are dominant.
The decrease in arterial oxygen saturation found initially after both anaesthetic agents may probably be explained by the observed change in ventilation, but the nature and cause of this change is not known. To exclude that the change in ventilation in some way was caused by the administration of the anaesthetic in the pulmonary artery a control experiment was performed where propanidid was injected into a a peripheral vein in the same dose. Right atrial pressure was recorded continuously and the pressure recording indicated the same pattern of hyperventilation followed by intermittent breathing.
SOMMAIRE
On a etudie chez 10 sujets volontaires, sains, du sexe masculin, les effets cardio-vasculaires engendres par une dose unique de deux anesthesiques de breve duree d'action et administres par voie intraveineuse: le methohexitone et la propanidide. Les doses utilisees qnt ete choisies en vue de determiner une anesth£sie clinique d'intensite et de duree similaires. Le methohexitone a provoque une augmentation initiale de la frequence cardiaque, sans modification de la pression arterielle et des pressions de remplissage. La difference C (a-v) O 2 a ete reduite, ce qui est en faveur d'une augmentation du debit cardiaque. L'augmentation de la frequence cardiaque a ete d'un meme ordre de grandeur, ce qui correspond a un effet inotrope negatif sans importance. La propanidide a determine une diminution initiale de la pression arterielle et une augmentation de la frequence cardiaque. Les pressions de remplissage ont ete legerement augmentees. La difference C (a-v) O 2 a pre'sente une diminution du meme ordre que celle notee apres administration de methohexitone. Une augmentation relativement plus importante de la frequence cardiaque, ainsi qu'un accroissement des pressions de remplissage indique l'existence pour la propanidide d'un effet inotrope negatif plus nettement precise. II semblerait tputefois que l'effet exerce par ces deux types d'agents soit avant tout d'ordre peripherique. 
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